The investigators hypothesize that the CSF concentrations of Celecoxib post dose are lower than plasma levels, take longer to reach peak concentration and are directly related to dose, genetics, and age. The investigators expect that Celecoxib will improve quality of life and reduce discomfort when administered before and after a lumbar puncture and bone marrow aspirate.